Skip to content
Search
Close
Search
Menu
  • Services
    • Services
      • BioAgilytix Diagnostics
      • Biomarker Menu
      • DMPK Assays
      • Dose Formulation Analysis
      • Method Development & Validation
      • Pharmacokinetic Analysis And Reports
      • Protein Binding Assays
      • Small Molecule Bioanalysis
      • Specimen Collection Kits
    • Solutions
      • Antibody Drug Conjugates
      • Biosimilars
      • CAR-T Cell Therapy
      • Gene Therapy
      • Immuno-Oncology
      • Modified & Novel Vehicles For Gene Therapy
      • Vaccines
    • Assay Focus
      • Assay Focus
      • Biomarkers
      • Cell-Based Assays
      • Immunogenicity
      • Pharmacokinetics
      • Toxicology Studies
    • Process Management
      • Process Management
      • Agricultural Biotechnology
      • Data Management
      • Industries Served
      • Pharma & Biotech
      • Project Management
      • Sample Management
    • Therapeutic Area Expertise
      • Therapeutic Area Expertise
      • Autoimmune
      • Metabolic
      • Neurology
      • Oncology
      • Virology
  • Technology
    • Our Platforms
      • ELISA
      • MSD-ECL
      • Flow Cytometry
      • Quantitative Real-Time PCR (qPCR)
      • Roche cobas Analyzer
      • Gyrolab
      • Ella
      • LI-COR Odyssey
      • Luminex
      • Biacore
      • ImmunoCAP
      • ELISpot
    • Automation
  • Company
    • About Us
    • Our Capabilities
    • Meet Our Team
    • Industries Served
    • Awards
    • Mission Vision & Values
    • Meet Our Partners
    • The BioAgilytix Way
    • Our Quality Commitment
    • US Headquarters
    • European Headquarters
    • Australian Headquarters
  • Resources
    • Resources
    • Gene & Cell Therapy Center
    • Testimonials
    • Science In 60
    • Our Blog
    • News
    • Case Studies
    • Molecular Moments Podcast
    • FAQ
    • Glossary
    • Articles
    • Podcasts
    • Events
    • Webinars
    • EBooks
    • Infographics
    • Videos
    • Guidance
    • Posters
    • Brochures
    • Papers
  • News
    • News
    • Press Kit
  • Careers
    • Careers at BioAgilytix
    • Why BioAgilytix
    • Who Is Our Team
    • How You’ll Benefit
    • What You’ll Enable
SPEAK TO A SCIENTIST
  • Services

    Services

    BioAgilytix Diagnostics

    Biomarker Menu

    DMPK Assays

    Dose Formulation Analysis

    Method Development & Validation

    Our Capabilities

    Pharmacokinetic Analysis & Reports

    Protein Binding Assays

    Small Molecule Bioanalysis

    Specimen Collection Kits

    Solutions

    Antibody Drug Conjugates

    Biosimilars

    CAR-T Cell Therapy

    Gene Therapy

    Immuno-oncology

    Modified & Novel Vehicles for Gene Therapy

    Vaccines

    Assay Focus

    Biomarkers

    Cell-Based Assays

    Immunogenicity

    Pharmacokinetics

    Toxicology Studies

    Process Management

    Agricultural Biotechnology

    Data Management

    Industries Served

    Pharma & Biotech

    Project Management

    Sample Management

    Therapeutic Area Expertise

    Autoimmune

    Metabolic

    Neurology

    Oncology

    Virology

  • Technology

    Our Platforms

    Learn More

    QuantStudio 7 Flex

    (qPCR)

    Luminex Flexmap 3D

    (Luminex)

    Flow Cytometry

    Roche cobas® e411 Analyzer

    (Automated Immunoassays)

    Meso Scale Discovery Sector S600, and QuickPlex SQ 120

    (MSD-Multiplex ECLIA)

    Biacore T200™

    (SPR Biomarker Interactions)

    Phadia 200

    (ImmunoCAP)

    LI-COR Odyssey

    (Western Blot Imager)

    ELISpot reader

    (Immune Cell Cytokine Release)

    Gyrolab™

    (Low Volume Automated ELISA)

    ProteinSimple Ella

    (Multiplex Immunoassay)

    Biotek Synergy NE02 Plate Reader

    (ELISA)

    ddPCR

    Droplet Digital PCR QX200, QX One

    Automation

    Learn More

    Hamilton Microlab® NIMBUS

    Hamilton Microlab® STARlet

    Biomek FXP

    BioTek Microplate Washer

    BioTek Precision™ 2000

    BioTek MultiFlo™ FX

    Perkin Elmer Janus G3 Liquid Handler

    Mantis

    Integra Assist Plus

    Your Partner for Global Bioanalytical Services

    Delivering Premier Science, Deep Experience, and Proven Quality
  • Company

    About Us

    Our Capabilities

    Meet Our Team

    Industries Served

    Awards & Certifications

    Mission Vision & values

    Meet our partners

    The BioAgilytix Way

    Our Quality Commitment

    Australian Advantage

    Click On Location To Learn More

    SAN DIEGO LAB

    ~34,000 sq. ft.

    CRO

    Immunoassay

    Mass Spectrometry

    USA HQ (DURHAM)

    ~265,000 sq. ft.

    Discovery

    Preclinical/clinal

    Manufacturing

    BOSTON LAB

    ~22,000 sq. ft.

    Bioanalytical Services

    Diagnostic Testing

    EUROPEAN HQ (HAMBURG)

    ~2,900 m2 (31,000 sq. ft.)

    Assay Development

    Validation

    Sample Analysis

    Global Disease Studies

    MELBOURNE LAB

    2,777 Square Meters

    Pharmacokinetics (PK)
    Pharmacodynamics (PD)
    Virology
    Immunology
    FIH trials & early-phase clinical trials
    Central laboratory services

    BRISBANE LAB

    1,566 Square Meters

    Pharmacokinetics (PK)
    Pharmacodynamics (PD)
    Virology
    Immunology
    FIH trials & early-phase clinical trials
    Central laboratory services

    Speak to our team

    Explore the capabilities of each platform in more detail to learn which option will be best for your unique study. Our team is available for specific guidance on platform selection.

  • Resources

    Resources

    Gene & Cell Therapy Center

    Testimonials

    Our Blog

    News

    Case Studies

    Molecular Moments Podcast

    Science in 60

    FAQ

    Glossary

    Scientific Posters

    Resource Center

    Articles

    Podcasts

    Events

    Webinars

    eBooks

    Infographics

    Videos

    Guidance

    Posters

    Brochures

    Papers

    [EPISODE 24] Dr. David Berkowitz Talks Enzymes, Radiation, And The Lincoln Marathon

    January 6, 2023

    On this episode of Molecular Moments, Chad Briscoe speaks with Dr. David Berkowitz, Director of the Division of Chemistry at

    Share This
    Read More »

    Immunogenicity Testing For Biosimilars

    December 19, 2022

    Entering the biosimilars market is an enticing prospect for many biopharma companies, offering the potential for reduced development and manufacturing

    Share This
    Read More »

    Bioanalytical Needs And Biosimilars: How Does The Molecule Compare?

    January 3, 2023

    Once the patent on a previously ground-breaking blockbuster molecule comes to an end, there is an opportunity for biosimilar versions

    Share This
    Read More »

    Trends Paving The Way For An Influx Of Biosimilar Development

    January 3, 2023

    Promising broader patient access to critical medicines, biosimilars offer a more cost-effective alternative therapeutic option compared with originator products. With

    Share This
    Read More »
  • News

    Recent News

    BioAgilytix Expands to Second Campus in Durham, NC

    October 19, 2022

    78,000 Square Feet of Lab and Office Space Added in the First of a Multi-Phase Expansion Durham, NC, October 19,

    Share This
    Read More »

    BioAgilytix Announces Appointment Of Dr. Linda Robbie As Chief Operating Officer

    August 17, 2022

    Durham, NC, August 17, 2022 – BioAgilytix Labs, LLC (BioAgilytix), a leading contract research organization supporting pharmaceutical and biotech partners in

    Share This
    Read More »

    Events

    Press Kit

    Recent News

    Immunogenicity Testing For Biosimilars

    December 19, 2022

    Entering the biosimilars market is an enticing prospect for many biopharma companies, offering the potential for reduced development and manufacturing

    Share This
    Read More »

    The State Of The Biosimilars Market

    December 13, 2022

    3 key challenges facing the biosimilars space in 2023 In 2010, the biopharma industry saw an abrupt patent cliff: a

    Share This
    Read More »

    How Have Advanced Drug Modalities Impacted Bioanalysis?

    November 22, 2022

    As therapeutic drugs have grown in complexity, so too have the bioanalysis techniques to support these products. Bioanalysis of small molecule

    Share This
    Read More »

    Events

  • Careers

    Careers

    View Current Career Opportunities

    Why
    BioAgilytix

    Because the best science
    demands the best people.

    Read More

    Who
    is on Our Team

    Meet our Global Colleagues.
    Read More

    How
    You’ll Benefit

    Explore our benefit program
    and company perks.

    Read More

    What
    You’ll Enable

    See how your work will
    change patients’ lives.

    Read More

    Careers

    Why BioAgilytix

    Who Is On Our Team

    How You’ll Benefit

    What You’ll Enable

    Current Opportunities

    Company

  • Services

    Services

    BioAgilytix Diagnostics

    Biomarker Menu

    DMPK Assays

    Dose Formulation Analysis

    Method Development & Validation

    Our Capabilities

    Pharmacokinetic Analysis & Reports

    Protein Binding Assays

    Small Molecule Bioanalysis

    Specimen Collection Kits

    Solutions

    Antibody Drug Conjugates

    Biosimilars

    CAR-T Cell Therapy

    Gene Therapy

    Immuno-oncology

    Modified & Novel Vehicles for Gene Therapy

    Vaccines

    Assay Focus

    Biomarkers

    Cell-Based Assays

    Immunogenicity

    Pharmacokinetics

    Toxicology Studies

    Process Management

    Agricultural Biotechnology

    Data Management

    Industries Served

    Pharma & Biotech

    Project Management

    Sample Management

    Therapeutic Area Expertise

    Autoimmune

    Metabolic

    Neurology

    Oncology

    Virology

  • Technology

    Our Platforms

    Learn More

    QuantStudio 7 Flex

    (qPCR)

    Luminex Flexmap 3D

    (Luminex)

    Flow Cytometry

    Roche cobas® e411 Analyzer

    (Automated Immunoassays)

    Meso Scale Discovery Sector S600, and QuickPlex SQ 120

    (MSD-Multiplex ECLIA)

    Biacore T200™

    (SPR Biomarker Interactions)

    Phadia 200

    (ImmunoCAP)

    LI-COR Odyssey

    (Western Blot Imager)

    ELISpot reader

    (Immune Cell Cytokine Release)

    Gyrolab™

    (Low Volume Automated ELISA)

    ProteinSimple Ella

    (Multiplex Immunoassay)

    Biotek Synergy NE02 Plate Reader

    (ELISA)

    ddPCR

    Droplet Digital PCR QX200, QX One

    Automation

    Learn More

    Hamilton Microlab® NIMBUS

    Hamilton Microlab® STARlet

    Biomek FXP

    BioTek Microplate Washer

    BioTek Precision™ 2000

    BioTek MultiFlo™ FX

    Perkin Elmer Janus G3 Liquid Handler

    Mantis

    Integra Assist Plus

    Your Partner for Global Bioanalytical Services

    Delivering Premier Science, Deep Experience, and Proven Quality
  • Company

    About Us

    Our Capabilities

    Meet Our Team

    Industries Served

    Awards & Certifications

    Mission Vision & values

    Meet our partners

    The BioAgilytix Way

    Our Quality Commitment

    Australian Advantage

    Click On Location To Learn More

    SAN DIEGO LAB

    ~34,000 sq. ft.

    CRO

    Immunoassay

    Mass Spectrometry

    USA HQ (DURHAM)

    ~265,000 sq. ft.

    Discovery

    Preclinical/clinal

    Manufacturing

    BOSTON LAB

    ~22,000 sq. ft.

    Bioanalytical Services

    Diagnostic Testing

    EUROPEAN HQ (HAMBURG)

    ~2,900 m2 (31,000 sq. ft.)

    Assay Development

    Validation

    Sample Analysis

    Global Disease Studies

    MELBOURNE LAB

    2,777 Square Meters

    Pharmacokinetics (PK)
    Pharmacodynamics (PD)
    Virology
    Immunology
    FIH trials & early-phase clinical trials
    Central laboratory services

    BRISBANE LAB

    1,566 Square Meters

    Pharmacokinetics (PK)
    Pharmacodynamics (PD)
    Virology
    Immunology
    FIH trials & early-phase clinical trials
    Central laboratory services

    Speak to our team

    Explore the capabilities of each platform in more detail to learn which option will be best for your unique study. Our team is available for specific guidance on platform selection.

  • Resources

    Resources

    Gene & Cell Therapy Center

    Testimonials

    Our Blog

    News

    Case Studies

    Molecular Moments Podcast

    Science in 60

    FAQ

    Glossary

    Scientific Posters

    Resource Center

    Articles

    Podcasts

    Events

    Webinars

    eBooks

    Infographics

    Videos

    Guidance

    Posters

    Brochures

    Papers

    [EPISODE 24] Dr. David Berkowitz Talks Enzymes, Radiation, And The Lincoln Marathon

    January 6, 2023

    On this episode of Molecular Moments, Chad Briscoe speaks with Dr. David Berkowitz, Director of the Division of Chemistry at

    Share This
    Read More »

    Immunogenicity Testing For Biosimilars

    December 19, 2022

    Entering the biosimilars market is an enticing prospect for many biopharma companies, offering the potential for reduced development and manufacturing

    Share This
    Read More »

    Bioanalytical Needs And Biosimilars: How Does The Molecule Compare?

    January 3, 2023

    Once the patent on a previously ground-breaking blockbuster molecule comes to an end, there is an opportunity for biosimilar versions

    Share This
    Read More »

    Trends Paving The Way For An Influx Of Biosimilar Development

    January 3, 2023

    Promising broader patient access to critical medicines, biosimilars offer a more cost-effective alternative therapeutic option compared with originator products. With

    Share This
    Read More »
  • News

    Recent News

    BioAgilytix Expands to Second Campus in Durham, NC

    October 19, 2022

    78,000 Square Feet of Lab and Office Space Added in the First of a Multi-Phase Expansion Durham, NC, October 19,

    Share This
    Read More »

    BioAgilytix Announces Appointment Of Dr. Linda Robbie As Chief Operating Officer

    August 17, 2022

    Durham, NC, August 17, 2022 – BioAgilytix Labs, LLC (BioAgilytix), a leading contract research organization supporting pharmaceutical and biotech partners in

    Share This
    Read More »

    Events

    Press Kit

    Recent News

    Immunogenicity Testing For Biosimilars

    December 19, 2022

    Entering the biosimilars market is an enticing prospect for many biopharma companies, offering the potential for reduced development and manufacturing

    Share This
    Read More »

    The State Of The Biosimilars Market

    December 13, 2022

    3 key challenges facing the biosimilars space in 2023 In 2010, the biopharma industry saw an abrupt patent cliff: a

    Share This
    Read More »

    How Have Advanced Drug Modalities Impacted Bioanalysis?

    November 22, 2022

    As therapeutic drugs have grown in complexity, so too have the bioanalysis techniques to support these products. Bioanalysis of small molecule

    Share This
    Read More »

    Events

  • Careers

    Careers

    View Current Career Opportunities

    Why
    BioAgilytix

    Because the best science
    demands the best people.

    Read More

    Who
    is on Our Team

    Meet our Global Colleagues.
    Read More

    How
    You’ll Benefit

    Explore our benefit program
    and company perks.

    Read More

    What
    You’ll Enable

    See how your work will
    change patients’ lives.

    Read More

    Careers

    Why BioAgilytix

    Who Is On Our Team

    How You’ll Benefit

    What You’ll Enable

    Current Opportunities

    Company

Toxicokinetics of Pirfenidone in Dogs Following Inhalation in a Nebulized Aerosol Formulation

CONTACT US
↑
USA HQ

2300 Englert Dr

Durham, NC, 27713

919-381-6097

Fax 919-381-6099

San Diego Laboratory

9050 Camino Santa Fe

San Diego, CA 92121

858-652-4600

Fax 858-652-4699

Brisbane Laboratory

37 Kent St, Woolloongabba

Queensland, 4102, Australia

Subscribe to Our Newsletter
USA HQ

2300 Englert Dr

Durham, NC, 27713

919-381-6097

Fax 919-381-6099

San Diego Laboratory

9050 Camino Santa Fe

San Diego, CA 92121

858-652-4600

Fax 858-652-4699

Brisbane Laboratory

37 Kent St,Woolloongabba

Queensland, 4102, Australia

Boston Laboratory

1320 Soldiers Field Road

Boston, MA, 02135

617-456-0700

Fax 617-456-0701

Boston Laboratory

1320 Soldiers Field Road

Boston, MA, 02135

617-456-0700

Fax 617-456-0701

European HQ

Lademannbogen 10

22339 Hamburg Germany

+49 405267790

Melbourne Laboratory

85 Commercial Road, Melbourne

Victoria, 3004, Australia

+61 3 9282 2184

Copyright © 2023 BioAgilytix Labs. All rights reserved. Terms of Use | Privacy Notice
European HQ

Lademannbogen 10

22339 Hamburg Germany

+49 405267790

Melbourne Laboratory

85 Commercial Road, Melbourne

Victoria, 3004, Australia

+61 3 9282 2184

Subscribe to Our Newsletter

Copyright © 2023 BioAgilytix Labs.

All rights reserved.

CONTACT US
↑
Durham Lab (USA HQ)

2300 Englert Dr
Durham, NC, 27713
919-381-6097
Fax 919-381-6099

Morrisville Lab
5927 S. Miami Blvd. Suite 100 Morrisville, NC 27703 919-381-6097 Fax 919-381-6099
Boston Lab

1320 Soldiers Field Road

Boston, MA, 02135

617-456-0700

Fax 617-456-0701

San Diego Lab

9050 Camino Santa Fe

San Diego, CA 92121

858-652-4600

Fax 858-652-4699

European HQ

Lademannbogen 10

22339 Hamburg Germany

+49 405267790

Brisbane Lab

37 Kent St, Woolloongabba

Queensland, 4102, Australia

Melbourne Lab

85 Commercial Road, Melbourne

Victoria, 3004, Australia

03 9282 2184

Subscribe to Our Newsletter

Copyright © 2023 BioAgilytix Labs.

All rights reserved.
Terms of Use | Privacy Notice

Durham Lab (USA HQ)

2300 Englert Dr
Durham, NC, 27713
919-381-6097
Fax 919-381-6099

Morrisville Lab

5927 S. Miami Blvd. Suite 100
Morrisville, NC 27703
919-381-6097
Fax 919-381-6099

Boston Lab

1320 Soldiers Field Road

Boston, MA, 02135

617-456-0700

Fax 617-456-0701

San Diego Lab

9050 Camino Santa Fe

San Diego, CA 92121

858-652-4600

Fax 858-652-4699

European HQ

Lademannbogen 10

22339 Hamburg Germany

+49 405267790

Brisbane Lab

37 Kent St,Woolloongabba

Queensland, 4102, Australia

Melbourne Lab

85 Commercial Road, Melbourne

Victoria, 3004, Australia

03 9282 2184

Subscribe to Our Newsletter

Copyright © 2023 BioAgilytix Labs.

All rights reserved.

Thank you!

You can access the recording at:

Click Here to View

 

Subscribe to Our Newsletter

    I consent to receive communications (which may include, phone, email, social, and re-targeting ads) from BioAgilytix. I understand I may proactively manage my preferences or opt-out of communications with BioAgilytix at any time using the unsubscribe link provided in all of BioAgilytix’s email communications and can learn more by reading the privacy policy.

    Yes I confirm that I am over the age of 16 and I consent to communications from BioAgilytix.